NexPoint Real Estate Finance, Inc.

What they do

NREF originates and invests in senior loans, mezzanine loans, preferred equity, convertible notes, and CMBS securitizations tied to multifamily and single-family rental properties. It also holds interests in multifamily properties and common equity investments. Substantially all business is conducted through its operating partnership, and it is externally managed by NexPoint Real Estate Advisors, which receives a 1.5% annual management fee on Equity.

Revenue drivers

• Senior loans and CMBS — First-lien mortgage loans and CMBS securitizations generate interest income; the portfolio had $1.1 billion outstanding across 85 investments as of June 30, 2026.
• Preferred equity and mezzanine — Preferred equity and mezzanine loans earn fixed or floating coupons; life sciences represented 39.4% and multifamily 37.6% of the investment portfolio.
• CMBS I/O strips — Interest-only strips on multifamily CMBS provide current yield and are reported as separate investment positions.
• Multifamily properties — The company owns select multifamily properties, including Alexander at the District, Ridgeview Place and Mag & May, which generate rental income.

Recent performance

For Q2 2026, NREF reported net income attributable to common stockholders of $5.4 million, or $0.29 per diluted share, and cash available for distribution of $13.9 million, or $0.58 per diluted common share. The portfolio totaled $1.1 billion across 85 investments as of June 30, 2026, with weighted-average LTV of 63.4% and DSCR of 1.39x on senior loans, CMBS, CMBS I/O strips, preferred equity and mezzanine investments. During the quarter the company funded loans totaling $7.3 million at SOFR + 900 bps and $62.8 million across two loans at a 14.0% coupon.

Strategy

Management focuses on originating and structuring investments in multifamily, single-family rental, self-storage, industrial and life science sectors, primarily in the top 50 MSAs. The company also lends to redevelopment and development projects where it sees strong sponsorship and clear cost-basis detachment points. In Q2 2026, it raised $22.6 million in gross proceeds from a Series C preferred stock offering, and it continues to underwrite new opportunities as traditional lenders pull back.

Risks

• Concentration risk — The portfolio is heavily concentrated in life sciences (39.4%) and multifamily (37.6%), so adverse conditions in those sectors could materially affect results.
• Interest rate and credit spread risk — Fluctuations in interest rates and credit spreads could reduce income on loans and investments, and the company has floating-rate exposure through SOFR-linked loans.
• External management conflicts — The company is externally managed by an affiliate of its sponsor, and the management agreement automatically renews for successive one-year terms unless terminated.
• Real estate and loan default risk — Loans and investments are exposed to delinquency, foreclosure and loss, and the portfolio includes preferred equity and mezzanine positions that are subordinated to senior debt.

Outlook

For Q3 2026, management guides EAD per diluted common share of $0.43 at the midpoint, with estimated net income between $18.5 million and $20.9 million before preferred allocations. The company declared a third quarter dividend of $0.50 per common share on July 27, 2026. Management stated that rate uncertainty is causing traditional lenders to pull back, allowing NREF to underwrite new opportunities from a position of strength.